<p>The following adverse reactions have been identified during post-approval use of trospium chloride. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.</p>

<ul>
	<li>Gastrointestinal: gastritis</li>
	<li>Cardiovascular: palpitations, supraventricular tachycardia, chest pain, syncope,</li>
	<li>hypertensive crisis</li>
	<li>Immunological: Stevens-Johnson syndrome, anaphylactic reaction, angioedema</li>
	<li>Nervous System: dizziness, confusion, vision abnormal, hallucinations, somnolence and delirium</li>
	<li>Musculoskeletal: rhabdomyolysis</li>
	<li>General: rash</li>
</ul>